Dr. Elizabeth M. Berry-Kravis

Pediatric Neurology | Pediatrics | Psychiatry
1725 W Harrison St, 
Chicago, IL 
Accepting New Patients
Offers Telehealth
1725 W Harrison St, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Elizabeth Berry-Kravis is a Pediatric Neurologist and a Pediatrics provider in Chicago, Illinois. Dr. Berry-Kravis is rated as an Experienced provider by MediFind in the treatment of Familial Dysautonomia. Her top areas of expertise are Fragile X Syndrome, Niemann-Pick Disease, Autism Spectrum Disorder, and Rett Syndrome. Dr. Berry-Kravis is currently accepting new patients.

Her clinical research consists of co-authoring 279 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Neurology
Pediatrics
Psychiatry
Licenses
Pediatrics in IL
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

RUSH UNIVERSITY MEDICAL GROUP
1725 W Harrison St, Chicago, IL 60612
Other Locations
RUSH UNIVERSITY MEDICAL GROUP
1800 Mcdonough Rd, Suite 203, Hoffman Estates, IL 60192
RUSH UNIVERSITY MEDICAL GROUP
1700 W Van Buren St, Chicago, IL 60612

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children, Adolescents and Young Adults With Fragile X Syndrome - RECONNECT
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children, Adolescents and Young Adults With Fragile X Syndrome - RECONNECT
Enrollment Status: Completed
Publish Date: December 17, 2025
Intervention Type: Drug
Study Drug: ZYN002
Study Phase: Phase 3
Cerliponase Alfa Observational Study
Cerliponase Alfa Observational Study
Enrollment Status: Active_not_recruiting
Publish Date: May 25, 2025
Intervention Type: Drug, Device
Mapping the Phenotype in Adults With Phelan-McDermid Syndrome
Mapping the Phenotype in Adults With Phelan-McDermid Syndrome
Enrollment Status: Completed
Publish Date: February 18, 2025
Intervention Type: Other
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
Enrollment Status: Active_not_recruiting
Publish Date: February 17, 2025
A Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study of BPN14770 in Adult Males With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study of BPN14770 in Adult Males With Fragile X Syndrome
Enrollment Status: Completed
Publish Date: December 19, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Assess the Safety, Tolerability and Efficacy of Oral Ketamine for Patients With Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Assess the Safety, Tolerability and Efficacy of Oral Ketamine for Patients With Rett Syndrome
Enrollment Status: Completed
Publish Date: May 28, 2024
Intervention Type: Drug
Study Drug: Ketamine
Study Phase: Phase 2
A Phase 2, Placebo-controlled, Adaptive Design Study to Explore the Safety and Efficacy of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) and Possible Other Treatments in Adolescent and Adult Males With Fragile X Syndrome (FXS)
A Phase 2, Placebo-controlled, Adaptive Design Study to Explore the Safety and Efficacy of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) and Possible Other Treatments in Adolescent and Adult Males With Fragile X Syndrome (FXS)
Enrollment Status: Withdrawn
Publish Date: December 08, 2022
Intervention Type: Drug
Study Drugs: Sulindac, Gaboxadol
Study Phase: Phase 2
Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol
Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol
Enrollment Status: Completed
Publish Date: August 05, 2021
Biobanking of Rett Syndrome and Related Disorders Protocol
Biobanking of Rett Syndrome and Related Disorders Protocol
Enrollment Status: Completed
Publish Date: August 05, 2021
Double-Blind, Placebo-Controlled Proof of Concept Study in Youth With Fragile X Syndrome
Double-Blind, Placebo-Controlled Proof of Concept Study in Youth With Fragile X Syndrome
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 1
View 9 Less Clinical Trials

279 Total Publications

Early Pragmatic Communication in Autism and Fragile X Syndrome.
Early Pragmatic Communication in Autism and Fragile X Syndrome.
Journal: Journal of speech, language, and hearing research : JSLHR
Published: November 21, 2025
Similar Doctors
Experienced in Familial Dysautonomia
Dr. Divakar S. Mithal
Pediatric Neurology | Psychiatry | Neurology
Experienced in Familial Dysautonomia
Dr. Divakar S. Mithal
Pediatric Neurology | Psychiatry | Neurology

Lurie Children's Medical Group Inc.

225 E Chicago Ave, 
Chicago, IL 
 (3.0 miles away)
312-227-6415
Languages Spoken:
English
See accepted insurances

Divakar Mithal is a Pediatric Neurologist and a Psychiatrist in Chicago, Illinois. Dr. Mithal is rated as an Advanced provider by MediFind in the treatment of Familial Dysautonomia. His top areas of expertise are Leigh Syndrome, Maternally Inherited Leigh Syndrome, MELAS Syndrome, and Pulmonary Arteriovenous Malformation (PAVM).

Experienced in Familial Dysautonomia
Dr. Leslie S. Finkel
Pediatric Neurology | Pediatrics | Neurology
Experienced in Familial Dysautonomia
Dr. Leslie S. Finkel
Pediatric Neurology | Pediatrics | Neurology
1000 Central St Ste 800, 
Evanston, IL 
 (12.7 miles away)
847-570-2577
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Leslie Finkel is a Pediatric Neurologist and a Pediatrics provider in Evanston, Illinois. Dr. Finkel is rated as an Advanced provider by MediFind in the treatment of Familial Dysautonomia. Her top areas of expertise are Migraine, Genetic Epilepsy with Febrile Seizures Plus (GEFS+), Migraine with Brainstem Aura, and Seizures. Dr. Finkel is currently accepting new patients.

Experienced in Familial Dysautonomia
Dr. Talia C. Shear
Pediatrics | Neurology
Experienced in Familial Dysautonomia
Dr. Talia C. Shear
Pediatrics | Neurology
225 E Chicago Ave, 
Chicago, IL 
 (3.0 miles away)
312-227-6833
Languages Spoken:
English, Spanish
See accepted insurances

Talia Shear is a Pediatrics specialist and a Neurologist in Chicago, Illinois. Dr. Shear is rated as an Advanced provider by MediFind in the treatment of Familial Dysautonomia. Her top areas of expertise are Status Epilepticus, Microcephaly, Microcephaly with Spastic Quadriplegia, and Zika Virus Disease.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Berry-Kravis's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 31 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile